REgeneration of inner ear hair cells with GAmma-secretase INhibitors

The REGAIN project aims to develop and test a new drug administered to the ear to treat hearing loss caused by the loss of sensory hair cells in the inner ear.

Welcome to the REGAIN Patient Information page!

This section is designed for patients who are interested in participating in the REGAIN trial.

A drug is in development that may be able to restore hearing loss. The REGAIN study aims to test how safe the drug is and if it affects the ability to hear.

Recruitment for the trial isn't open yet, but we expect it to begin in the second half of 2017. If you'd like us to contact you with more information when the study is open to recruitment, please complete your details in the form on your right.

By providing your details you agree for us to contact you with information about taking part in the REGAIN study when recruitment opens. If you change your mind and no longer want to hear from us about the trial please contact us. Your details are secure with us and will be handled in accordance with the Data Protection Act. We will never give them away or sell them. We will delete this data after you have been contacted.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 634893.
I am interested in participating in the REGAIN clinical trial